Current News

Country:
Operation:
Search for:
Overview Companies Countries Top News Tag Clouds
All   Business   Career   Cooperation   Finances   Laws   Manufacturing   Market
People   Politics   Products   Research   Technology

Contact | Print version | PDF version | Send article | RSS-FeedRSS-Feed

Genomatix signs nationwide license with the French National Genomic Research Consortium (CNRG)

21 Jul 2005 - Genomatix Software GmbH (Munich) announced today that it has closed a contract with the French National Genomic Research Consortium (CNRG). According to Klaus May, Genomatix? head of sales and marketing, this contract covers preferred access for all researchers from the French National Genopoles Network to GenomatixSuitePE.

 
GenomatixSuitePE enables biologists to discover, explore and understand biologically relevant pathways down to the molecular level. Applying the GenomatixSuitePE pipeline to a researcher's set of genes e. g. from a microarray analysis, generates the full biological network, allowing for functional analysis of the most relevant sub-network and enables understanding of gene regulatory mechanisms on DNA Sequence level.
 
Klaus May says : "With the French CNRG, the CSC in Finland, and the NIH in the U.S.A. we now have three governmental institutions who have recognized the value of our technology for their national academic research. We further strive to coordinate individual academic subscriptions to a larger institution-wide or nation-wide level ."
 
Part of the contract provides for on site training and scientific seminars at the different French "Genopole" clusters.
 
Contact / Request Information
Additional information

French National Institute of Health and Medical Research - Institut national de la santé et de la recherche médicale (Inserm)
France

News
-  29 May 2007 - Immunization Against Type 1 Diabetes - Mice Successfully Treated
-  15 Nov 2006 - Sanofi-aventis, Innogenetics, and Inserm to collaborate on Alzheimer's disease
-  14 Mar 2005 - "The Sword and the Shield" - How bacteria develop their virulence by creating multiple variants
 
MyBionity.COM
Newsletter Subscription
Your e-mail:
Top  
© 2001-2008 Chemie.DE Information Service GmbH
a Life Science Network Division

 www.Chemie.DE   www.Bionity.COM   www.ChemEurope.COM   www.ChemieKarriere.NET   www.BioKarriere.NET